beta-lactams has been researched along with morpholine in 3 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (morpholine) | Trials (morpholine) | Recent Studies (post-2010) (morpholine) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 330 | 0 | 126 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| D'hooghe, M; De Kimpe, N; Van Brabandt, W; Vanwalleghem, M | 1 |
| Bayrak, H; Cebeci, YU; Şirin, Y | 1 |
| Brunel, JM; Digiorgio, C; Douafer, H; Gholami, A; Heiran, R; Jarrahpour, A; Riazimontazer, E; Sepehri, S; Turos, E | 1 |
3 other study(ies) available for beta-lactams and morpholine
| Article | Year |
|---|---|
Asymmetric synthesis of 1-(2- and 3-haloalkyl)azetidin-2-ones as precursors for novel piperazine, morpholine, and 1,4-diazepane annulated beta-lactams.
Topics: Azetidines; beta-Lactams; Chemistry, Organic; Magnetic Resonance Spectroscopy; Molecular Structure; Morpholines; Piperazine; Piperazines | 2006 |
Synthesis of novel Schiff bases and azol-β-lactam derivatives starting from morpholine and thiomorpholine and investigation of their antitubercular, antiurease activity, acethylcolinesterase inhibition effect and antioxidant capacity.
Topics: Acetylcholinesterase; Antioxidants; Antitubercular Agents; beta-Lactams; Biphenyl Compounds; Dose-Response Relationship, Drug; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Morpholines; Mycobacterium smegmatis; Picrates; Schiff Bases; Structure-Activity Relationship; Urease | 2019 |
Synthesis, docking and evaluation of in vitro anti-inflammatory activity of novel morpholine capped β-lactam derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; beta-Lactams; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Lipopolysaccharides; Mice; Molecular Docking Simulation; Molecular Structure; Morpholines; Nitric Oxide; Nitric Oxide Synthase Type II; RAW 264.7 Cells; Structure-Activity Relationship | 2020 |